Concepedia

Kaku Fujiwara

KF

Statistics

Publications

2

Citations

50

H-Index

2

Active since

2022

Affiliations

Ono Pharmaceutical (Japan)(Current)

Gilead Sciences (United States)

Asahi Kasei (Japan)

Merck & Co., Inc., Rahway, NJ, USA (United States)

GlaxoSmithKline (United States)

Kaku Fujiwara is an author at Ono Pharmaceutical (Japan) specializing in molecular pharmacology, pharmacology, and cyclosporine interactions.

Publications per year

2022–2024

2

Publications

2

Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions

Tatsuki Mochizuki, Maciej J. Zamek‐Gliszczynski, Kenta Yoshida et al. · Clinical Pharmacology & Therapeutics · 2022 · 37 citations · Full text

, , +14

Effects of Cimetidine and Dolutegravir on the Endogenous Drug–Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers

Tomoki Koishikawa, Kaku Fujiwara, Kunal S. Taskar et al. · Clinical Pharmacology & Therapeutics · 2024 · 13 citations · Full text

, , +17

1–2 of 2